EUVIMEDEUVIMED entdecken
Crossref

The dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1 receptor agonist tirzepatide effects on body weight evolution, adiponectin, insulin and leptin levels in the combination of obesity, type 2 diabetes and menopause in mice

Pedro H Reis-Barbosa iD, Ilitch Marcondes-de-Castro iD, Thatiany S Marinho iD, Marcia Barbosa Aguila iD, Carlos A Mandarim-de-Lacerda iD

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Pedro H Reis-Barbosa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Morphometry, Metabolism, and Cardiovascular Disease, Institute of Biology, Biomedical Center, The University of the State of Rio de Jan…. Hauptthemen laut MEDLINE: Adiponectin, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor, Insulin. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Tirzepatide (Tzp), a novel dual agonist glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1, is approved for treating insulin resistance and obesity, and menopausal women consuming a high‐calorie diet are a target to study the Tzp effect. Therefore, we aimed to allometrically scale body weight (BW) in Tzp‐treated obese diabetic menopausal mice. Materials and Methods Three‐month‐old C57BL/6 female mice had bilateral ovariectomy (Ovx) or a sham procedure and for 12 weeks were fed a control diet or a high‐fat and high sucrose diet ( n = 120/each group [control (C), obese diabetic (Od), Ovx (O), sham (S), Tzp (T)]). Tzp was subcutaneously administered (10 nmol/kg) or vehicle once a day for an additional 4 weeks. The analysis considered log‐transformed data and the allometric equation log y = log a + b log x .

Results

Od and OdO showed more upward slopes than C and CO. In C, BW was non‐allometric by T administration. Od and OdO showed slightly positive slopes (more prominent in OdO than Od). OdT and OdOT showed negative slopes, significant intercepts, and more robust Pearson coefficients than untreated ones. A potent drug effect was seen with BW allometric decline. Interactions between diet versus Ovx and diet versus Tzp affected weight gain. Diet versus Ovx versus Tzp affected food intake.

Conclusions

A model was developed to show three usual factors observed in mature women. Notably, Tzp improved the metabolism and weight loss of OdO mice. Tzp‐treated mice showed negative allometric BW across treatment time, which is a quantitative assessment that allows better comparison between results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdiponectinDiabetes Mellitus, Type 2Glucagon-Like Peptide-1 ReceptorInsulinLeptinMenopauseObesityGlucagon-Like Peptide-1 Receptor AgonistsAnimalsFemaleMiceBody WeightDiet, High-FatGastric Inhibitory PolypeptideGlucagon-Like Peptide-2 ReceptorMice, Inbred C57BLOvariectomyTirzepatide

Stichwörter der Autor:innen

body weightdual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1 agoni…menopauseobesityontogenetic allometry

Substanzen

AdiponectinGastric Inhibitory PolypeptideGlucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide-2 ReceptorInsulinLeptinTirzepatideGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Laboratory of Morphometry, Metabolism, and Cardiovascular Disease, Institute of Biology, Biomedical Center, The University of the State of Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Pedro H Reis-Barbosa, Ilitch Marcondes-de-Castro, Thatiany S Marinho, Marcia Barbosa Aguila, Carlos A Mandarim-de-Lacerda

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Reis-Barbosa, P. H., Marcondes-de-Castro, I., Marinho, T. S., Aguila, M. B., & Mandarim-de-Lacerda, C. A. (2024). The dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1 receptor agonist tirzepatide effects on body weight evolution, adiponectin, insulin and leptin levels in the combination of obesity, type 2 diabetes and menopause in mice. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15820

Vancouver

Reis-Barbosa PH, Marcondes-de-Castro I, Marinho TS, Aguila MB, Mandarim-de-Lacerda CA. The dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1 receptor agonist tirzepatide effects on body weight evolution, adiponectin, insulin and leptin levels in the combination of obesity, type 2 diabetes and menopause in mice. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15820

BibTeX
@article{ReisBarbosa2024,
  author = {Reis-Barbosa, Pedro H and Marcondes-de-Castro, Ilitch and Marinho, Thatiany S and Aguila, Marcia Barbosa and Mandarim-de-Lacerda, Carlos A},
  title = {The dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1 receptor agonist tirzepatide effects on body weight evolution, adiponectin, insulin and leptin levels in the combination of obesity, type 2 diabetes and menopause in mice},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15820}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche